Home » Note to Readers

Note to Readers

Aug 25, 2011
Premium

Gene Silencing News will be on hiatus next week and will not publish on Thursday, Sept. 1. The next issue of the newsletter will go out to subscribers on Thursday, Sept. 7.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Related Articles

Sep 11, 2014

Note to Readers

Premium
Sep 11, 2014

NIH Awards More than $1M in microRNA Grant Funding in September

Premium
Jun 26, 2014

New Data Refute Role for RNAi in Mammalian Viral Defense

Premium
May 29, 2014

Benitec Patent Revoked by EPO; Company Licenses IP from Galapagos

Premium
Mar 13, 2014

New Study Points to Variability of RNAi Effect in Different Corn Rootworm Populations

Premium
Oct 16, 2014

With RNAi Screening Tech, Startup Recursion Aims to Repurpose Drugs for Rare Diseases

Premium

The Scan

This Week in Genome Research

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

To the Brink

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Just Like Your Old Pop

Researchers report that paternally inherited genes are more likely to be expressed in mice.

This Week in PNAS

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

What's Popular?

In miRNA/RNAi

  1. Study Demonstrates New shRNA Approach for Finding Tumor-suppressor Genes

  2. The Cancer Fight

    Premium

  3. Nobel Prize, Nastech Pharmaceutical, Open Biosystems, Southwest Research Institute, Sigma-Aldrich, CombiMatrix, Invitrogen

    Premium

  4. Gradalis Moves Cancer Vaccine with RNAi Component into Phase III

    Premium

  5. New Study Expands Number of microRNAs in Human Genome

    Premium

Sponsorships

Privacy Policy.  Copyright © 2015 Genomeweb LLC.  All Rights Reserved.